India, Sept. 28 -- The firm is a pharmaceutical company whose operations are diversified in formulation and active pharmaceutical ingredients (APIs). In 2026, the company moved the entire API operation to RPG Active Pharma with the aim of creating a platform exclusively for API manufacturing and business expansion. The RPGAP firm went ahead and acquired the Actis Generics as well as the API and intermediates of the Raghava Life Sciences.

The shares of RPG Life Sciences are currently trading at Rs. 2,976.50, down by 2.43%. The company has a market capitalization of Rs. 4,922.84 crore. The stock's 52 week high is Rs. 3,127.80 and its 52 week low is Rs. 1,733.00. In the past 6 months the stock has delivered a return of 60.23%.

What's The ...